O
OtoNexus
OtoNexus Medical Technologies, Inc. is commercializing a ground-breaking, patented, medical device to rapidly
About OtoNexus
OtoNexus Medical Technologies specializes in developing advanced diagnostic tools for primary care pediatricians, focusing on the accurate assessment of middle ear infections (otitis media). The company's flagship product is an advanced ultrasound otoscope that can instantly and accurately analyze the presence and type of effusion in the middle ear, a capability previously unavailable without invasive procedures. This device, which resembles a traditional otoscope and fits in a lab coat pocket, leverages unique and patented ultrasound technology to provide precise diagnoses. OtoNexus primarily serves primary care pediatricians and healthcare providers who treat children, a market that sees nearly every child in America experiencing at least one middle ear infection severe enough to require a doctor's visit. The business model revolves around the sale of these advanced diagnostic devices to healthcare providers, aiming to reduce unnecessary antibiotic prescriptions and improve clinical outcomes. Revenue is generated through direct sales of the otoscope and potentially through recurring revenue from service and maintenance contracts.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2010
- Headquarters
- Seattle, United States
- Employees
- 23
- Open positions
- None listed
- Dealroom signal
- 74.1/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Pediatrics, Health Diagnostics, Spinout, Ultrasound Sensors, DT and LS, science-based
- Technology
- Deep Tech
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| GRANT✓Other financing | Mar 2023 | $0 | — | US National Science Foundation | ↗ |
| OtherOther financing | Jan 2021 | $0 | — | Puget Sound Venture Club | — |
Growth signals
Latest recorded traffic for OtoNexus is 590 monthly website visits, down 70.5% over the last three months. OtoNexus's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
US National Science Foundation
Series A4 investors entered at this stage
Keiretsu Forum Northwest
Keiretsu Capital- PCPuget Sound Venture Club
Keiretsu Forum
Series B and later1 investor entered at this stage
Tech Coast Angels
Other known investors11 additional known investors
University of Washington
Astia
Cavendish Impact Capital- DIDellin Investments
Farvatn Venture
Mindshift Capital
SeaChange Fund- SFSeaChange Fund
Small Business Innovation Research
Southwest-Midwest National Pediatric Device Innovation Consortium
SWAN Venture Fund
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about OtoNexus on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See OtoNexus’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.